HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by LEE, K. Articles by BIALOUS, S. A. Search for Related Content PubMed PubMed Citation Articles by LEE, K. Articles by BIALOUS, S. A.

Corporate social responsibility: serious cause for concern

¹ London School of Hygiene & Tropical Medicine, UK; kelley.lee@lshtm.ac.uk
² Tobacco Policy International, USA; stella@bialous.com

The first 150 words of the full text of this article appear below.

The need for the public health community to remain wary of corporate social responsibility (CSR) strategy by companies associated with the tobacco industry was demonstrated at the World Cancer Congress hosted by the International Union Against Cancer (known by its French acronym - UICC) in Washington DC in July. Snuggled within a session on "The role of corporate citizens: Looking at the business community as volunteers" was a presentation entitled "The role of KPMG as a corporate citizen," during which the audience, numbering 60 or so cancer experts, were subjected to a glowing review of what the consultancy firm was "giving back" to society. KPMG International, a Swiss-based network of independent member firms, boasts 94 000 staff in 144 countries. Its long list of good works range from its Relay for Life fun runs to staff volunteering, with much of these funds raised given to cancer research. Such activities form . . . [Full text of this article]

This article has been cited by other articles:

				E. R. Gritz, L. Sarna, C. Dresler, and C. G. Healton Building a United Front: Aligning the Agendas for Tobacco Control, Lung Cancer Research, and Policy Cancer Epidemiol. Biomarkers Prev., May 1, 2007; 16(5): 859 - 863. [Abstract] [Full Text] [PDF]